• About Genmab
    • About Genmab
    • Board of Directors
    • Management Team
    • Partnerships
    • FAQ
  • Science & Research
    • Products In Development
    • Licensing Opportunities
    • Clinical Trials
    • Introduction to Antibodies
    • Antibody Technology
    • Next Generation Technology
    • Scientific Articles
  • Investor Center
    • Stock Quotes
    • Stock Information
    • Analysts
    • Events
    • Investor Contact
    • Corporate Documents
    • Warrant Scheme
  • Press Center
    • Recent News Releases
    • Archived News Releases
    • Press Contact
  • Careers
    • Career Opportunities
    • Denmark
  • Contact Genmab
    • Contact Genmab
    • Subscribe to Genmab News

Hot News

Arzerra Second Quarter 2010 Net Sales Figures...»
Genmab Announces Interim Results of Ofatumumab Phase II Study in Multiple Sclerosis...»
GlaxoSmithKline and Genmab Announce Amendment to Ofatumumab Agreement...»
Genmab announces Change in Management...»
More Genmab News Releases

Investor Center

  • Stock Quotes
  • Stock Information
  • Analysts
  • Events
  • Investor Contact
  • Corporate Documents
  • Warrant Scheme
  • Home
Print

Legal Notice
Use of this Site is subject to Important Legal Terms, which you are requested to read prior to proceeding.
© 2010 Genmab A/S
Investor Center » Events » 2010 » Kempen & Co. Life Sciences Conference, Brussels, Belgium

Kempen & Co. Life Sciences Conference, Brussels, Belgium

(back to Recent News)